MedCram’s December 2020 description identifies Roger Seheult as the contributor and Kyle Allred as the interviewer. The programme asked about vitamin D in both prevention and treatment while evidence on COVID-19 was still emerging.

Its references include an Israeli study comparing blood measurements with infection risk and a small hospital trial of calcifediol. Those sources address different stages, from susceptibility to a treatment question after admission.

Original sources

Source

"Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study"

“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”.

Publication details

“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”

Read more →